搜索临床试验以:anti-PD1 blockade
总计98393个结果
-
Xinqiao Hospital of ChongqingTCRCure Biopharma Ltd.未知
-
Shanghai Pulmonary Hospital, Shanghai, ChinaThe University of Hong Kong尚未招聘
-
Bioray LaboratoriesWuhan Union Hospital, China; Zhejiang University; Institute of Hematology & Blood Diseases Hospital...招聘中
-
Targovax Oy完全的PD1 阻断后进展的晚期或不可切除的黑色素瘤美国, 挪威
-
Beijing Tongren HospitalPeking Union Medical College Hospital; Beijing Tiantan Hospital; Xuanwu Hospital, Beijing; Beijing...未知抗NMDA受体脑炎
-
Second Affiliated Hospital of Guangzhou Medical...Hunan Zhaotai Yongren Medical Innovation Co. Ltd.招聘中
-
Centre Hospitalier Régional d'OrléansUniversity Hospital, Tours; French Anti-Doping Agency (AFLD)完全的
-
Symphogen A/S完全的
-
GERCOR - Multidisciplinary Oncology Cooperative...招聘中
-
Gustave Roussy, Cancer Campus, Grand Paris招聘中
-
Beth Israel Deaconess Medical CenterNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH)招聘中
-
National University of SingaporeKHANA Center for Population Health Research招聘中
-
National University, SingaporeKHANA Center for Population Health Research完全的
-
National Institute of Allergy and Infectious Diseases...招聘中
-
Zhejiang Cancer Hospital尚未招聘胃癌、HIPEC、抗 PD-1 抗体 Camrelizumab (SHR-1210)、化疗和手术中国
-
Annelies VerbonUniversity Hospital, Geneva; Erasmus Medical Center; Uppsala University Hospital; University of...未知
-
Keimyung University Dongsan Medical Center完全的
-
Shanghai Zhongshan HospitalRenJi Hospital; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Public... 和其他合作者招聘中
-
Ascopharm Groupe NovascoGroupe Hospitalier Pitie-Salpetriere; Medco Health Solutions, Inc.完全的
-
TILT Biotherapeutics Ltd.Merck Sharp & Dohme LLC招聘中铂耐药卵巢癌 | 铂类耐药输卵管癌 | 铂类耐药原发性腹膜癌 | 铂类难治性输卵管癌 | 铂类难治性原发性腹膜癌 | 铂类难治性卵巢癌 | 参与者对卡铂和/或顺铂过敏或严重不耐受的铂敏感性卵巢癌 | 参与者对卡铂和/或顺铂过敏或严重不耐受的铂敏感性输卵管癌 | 参与者对卡铂和/或顺铂过敏或严重不耐受的铂敏感原发性腹膜癌美国, 芬兰